vs
First Bancorp, Inc（FNLC）与TriSalus Life Sciences, Inc.（TLSI）财务数据对比。点击上方公司名可切换其他公司
First Bancorp, Inc的季度营收约是TriSalus Life Sciences, Inc.的2.0倍（$25.8M vs $13.2M），First Bancorp, Inc净利率更高（39.4% vs -73.9%，领先113.2%），TriSalus Life Sciences, Inc.同比增速更快（59.8% vs 17.5%），First Bancorp, Inc自由现金流更多（$34.6M vs $-2.5M），过去两年TriSalus Life Sciences, Inc.的营收复合增速更高（43.0% vs 18.1%）
第一银行公司（First Bancorp, Inc）是一家银行控股公司，其核心业务通过总部位于康涅狄格州斯坦福的爱国者国家银行（Patriot Bank NA）开展，相关 banking 业务也以PNBK代码在纳斯达克挂牌交易。
TriSalus生命科学公司是一家临床阶段生物技术企业，专注于免疫肿瘤学与介入肿瘤学领域，研发专有的靶向给药技术，用于提升肝脏、胰腺等难治性实体瘤患者的治疗效果，主要在北美市场开展临床合作及业务运营。
FNLC vs TLSI — 直观对比
营收规模更大
FNLC
是对方的2.0倍
$13.2M
营收增速更快
TLSI
高出42.3%
17.5%
净利率更高
FNLC
高出113.2%
-73.9%
自由现金流更多
FNLC
多$37.1M
$-2.5M
两年增速更快
TLSI
近两年复合增速
18.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $25.8M | $13.2M |
| 净利润 | $10.2M | $-9.8M |
| 毛利率 | — | 86.7% |
| 营业利润率 | 48.1% | -24.8% |
| 净利率 | 39.4% | -73.9% |
| 营收同比 | 17.5% | 59.8% |
| 净利润同比 | 39.7% | 3.5% |
| 每股收益（稀释后） | $0.91 | $-0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FNLCTLSI
| Q4 25 | $25.8M | $13.2M | ||
| Q3 25 | $24.5M | $11.6M | ||
| Q2 25 | $22.5M | $11.2M | ||
| Q1 25 | $21.8M | $9.2M | ||
| Q4 24 | $22.0M | $8.3M | ||
| Q3 24 | $20.5M | $7.3M | ||
| Q2 24 | $19.2M | $7.4M | ||
| Q1 24 | $18.5M | $6.5M |
净利润FNLCTLSI
| Q4 25 | $10.2M | $-9.8M | ||
| Q3 25 | $9.1M | $-10.8M | ||
| Q2 25 | $8.1M | $-8.3M | ||
| Q1 25 | $7.1M | $-10.4M | ||
| Q4 24 | $7.3M | $-10.1M | ||
| Q3 24 | $7.6M | $-2.4M | ||
| Q2 24 | $6.2M | $-4.3M | ||
| Q1 24 | $6.0M | $-13.2M |
毛利率FNLCTLSI
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 83.5% | ||
| Q2 25 | — | 83.9% | ||
| Q1 25 | — | 83.7% | ||
| Q4 24 | — | 85.3% | ||
| Q3 24 | — | 86.3% | ||
| Q2 24 | — | 87.6% | ||
| Q1 24 | — | 85.0% |
营业利润率FNLCTLSI
| Q4 25 | 48.1% | -24.8% | ||
| Q3 25 | 45.2% | -77.9% | ||
| Q2 25 | 43.7% | -65.4% | ||
| Q1 25 | 39.3% | -79.9% | ||
| Q4 24 | 39.5% | -91.8% | ||
| Q3 24 | 44.6% | -118.9% | ||
| Q2 24 | 38.8% | -111.0% | ||
| Q1 24 | 39.3% | -180.8% |
净利率FNLCTLSI
| Q4 25 | 39.4% | -73.9% | ||
| Q3 25 | 37.0% | -93.5% | ||
| Q2 25 | 35.8% | -73.9% | ||
| Q1 25 | 32.5% | -113.2% | ||
| Q4 24 | 33.1% | -122.4% | ||
| Q3 24 | 36.9% | -32.6% | ||
| Q2 24 | 32.1% | -58.8% | ||
| Q1 24 | 32.5% | -204.5% |
每股收益（稀释后）FNLCTLSI
| Q4 25 | $0.91 | $-0.22 | ||
| Q3 25 | $0.81 | $-0.96 | ||
| Q2 25 | $0.72 | $-0.27 | ||
| Q1 25 | $0.63 | $-0.39 | ||
| Q4 24 | $0.66 | $-0.38 | ||
| Q3 24 | $0.68 | $-0.12 | ||
| Q2 24 | $0.55 | $-0.21 | ||
| Q1 24 | $0.54 | $-0.60 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $20.4M |
| 总债务越低越好 | $95.5M | — |
| 股东权益账面价值 | $283.1M | $-33.9M |
| 总资产 | $3.2B | $35.3M |
| 负债/权益比越低杠杆越低 | 0.34× | — |
8季度趋势，按日历期对齐
现金及短期投资FNLCTLSI
| Q4 25 | — | $20.4M | ||
| Q3 25 | — | $22.7M | ||
| Q2 25 | — | $26.5M | ||
| Q1 25 | — | $13.0M | ||
| Q4 24 | — | $8.5M | ||
| Q3 24 | — | $11.3M | ||
| Q2 24 | — | $16.5M | ||
| Q1 24 | — | $4.0M |
总债务FNLCTLSI
| Q4 25 | $95.5M | — | ||
| Q3 25 | $95.5M | — | ||
| Q2 25 | $95.0M | — | ||
| Q1 25 | $70.0M | — | ||
| Q4 24 | $95.0M | — | ||
| Q3 24 | $95.0M | — | ||
| Q2 24 | $70.0M | — | ||
| Q1 24 | $70.0M | — |
股东权益FNLCTLSI
| Q4 25 | $283.1M | $-33.9M | ||
| Q3 25 | $274.6M | $-26.7M | ||
| Q2 25 | $265.5M | $-19.4M | ||
| Q1 25 | $259.7M | $-34.4M | ||
| Q4 24 | $252.5M | $-25.9M | ||
| Q3 24 | $256.8M | $-20.4M | ||
| Q2 24 | $244.7M | $-25.3M | ||
| Q1 24 | $242.6M | $-36.0M |
总资产FNLCTLSI
| Q4 25 | $3.2B | $35.3M | ||
| Q3 25 | $3.2B | $36.5M | ||
| Q2 25 | $3.2B | $41.3M | ||
| Q1 25 | $3.2B | $28.6M | ||
| Q4 24 | $3.2B | $24.0M | ||
| Q3 24 | $3.1B | $27.5M | ||
| Q2 24 | $3.1B | $32.4M | ||
| Q1 24 | $3.0B | $17.9M |
负债/权益比FNLCTLSI
| Q4 25 | 0.34× | — | ||
| Q3 25 | 0.35× | — | ||
| Q2 25 | 0.36× | — | ||
| Q1 25 | 0.27× | — | ||
| Q4 24 | 0.38× | — | ||
| Q3 24 | 0.37× | — | ||
| Q2 24 | 0.29× | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $37.8M | $-2.5M |
| 自由现金流经营现金流 - 资本支出 | $34.6M | $-2.5M |
| 自由现金流率自由现金流/营收 | 133.9% | -19.1% |
| 资本支出强度资本支出/营收 | 12.5% | 0.3% |
| 现金转化率经营现金流/净利润 | 3.72× | — |
| 过去12个月自由现金流最近4个季度 | $55.3M | $-19.1M |
8季度趋势，按日历期对齐
经营现金流FNLCTLSI
| Q4 25 | $37.8M | $-2.5M | ||
| Q3 25 | $12.9M | $-3.7M | ||
| Q2 25 | $7.4M | $-7.3M | ||
| Q1 25 | $2.2M | $-4.5M | ||
| Q4 24 | $26.0M | $-5.7M | ||
| Q3 24 | $9.8M | $-10.8M | ||
| Q2 24 | $6.4M | $-13.4M | ||
| Q1 24 | $-1.5M | $-10.9M |
自由现金流FNLCTLSI
| Q4 25 | $34.6M | $-2.5M | ||
| Q3 25 | $12.6M | $-3.9M | ||
| Q2 25 | $7.2M | $-7.4M | ||
| Q1 25 | $828.0K | $-5.3M | ||
| Q4 24 | $24.6M | $-5.8M | ||
| Q3 24 | $9.6M | $-11.0M | ||
| Q2 24 | $6.3M | $-13.5M | ||
| Q1 24 | $-1.8M | $-10.9M |
自由现金流率FNLCTLSI
| Q4 25 | 133.9% | -19.1% | ||
| Q3 25 | 51.4% | -33.9% | ||
| Q2 25 | 32.1% | -66.1% | ||
| Q1 25 | 3.8% | -57.3% | ||
| Q4 24 | 111.7% | -69.7% | ||
| Q3 24 | 47.0% | -149.9% | ||
| Q2 24 | 32.9% | -183.1% | ||
| Q1 24 | -9.8% | -169.3% |
资本支出强度FNLCTLSI
| Q4 25 | 12.5% | 0.3% | ||
| Q3 25 | 1.2% | 1.9% | ||
| Q2 25 | 0.6% | 0.8% | ||
| Q1 25 | 6.2% | 8.2% | ||
| Q4 24 | 6.7% | 0.6% | ||
| Q3 24 | 0.5% | 2.3% | ||
| Q2 24 | 0.3% | 0.8% | ||
| Q1 24 | 1.8% | 1.0% |
现金转化率FNLCTLSI
| Q4 25 | 3.72× | — | ||
| Q3 25 | 1.42× | — | ||
| Q2 25 | 0.91× | — | ||
| Q1 25 | 0.31× | — | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 1.29× | — | ||
| Q2 24 | 1.03× | — | ||
| Q1 24 | -0.25× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
